1887

Abstract

Merkel cell polyomavirus (MCPyV) has been suspected to cause chronic lymphocytic leukaemia (CLL) but previous data are inconsistent. We measured seroreactivities of nine polyomaviruses (MCPyV, BKPyV, JCPyV, LPyV, KIPyV, WUPyV, HPyV-6, HPyV-7 and TSPyV) in 359 CLL cases and 370 controls using bead-based multiplex serology technology. We additionally tested two herpesviruses (HSV-1 and CMV). Associations between disease and viral seroreactivities were assessed using logistic regression. All human viruses showed high seroprevalences (69–99 %) against structural proteins in controls but significantly lower viral seroprevalences in cases (58–94 %; OR range = 0.21–0.70, value < 0.05), except for MCPyV (OR = 0.79, 95 % CI = 0.54–1.16). Lower seroreactivity levels were observed among CLL subjects, with significant differences already observed at early stages of disease, unrelated to treatment status. Seroreactivities against polyomavirus related oncoproteins were almost null. Our data suggest no association for MCPyV polyomavirus with CLL development and an unlikely association for other polyomaviruses tested.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000167
2015-08-01
2021-10-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/8/2286.html?itemId=/content/journal/jgv/10.1099/vir.0.000167&mimeType=html&fmt=ahah

References

  1. Amend K.L., Turnbull B., Foskett N., Napalkov P., Kurth T., Seeger J. 2010; Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 75:1326–1332 [View Article][PubMed]
    [Google Scholar]
  2. Benavente Y., Garcia N., Domingo-Domenech E., Alvaro T., Font R., Zhang Y., de Sanjose S. 2005; Regular use of hair dyes and risk of lymphoma in Spain. Int J Epidemiol 34:1118–1122 [View Article][PubMed]
    [Google Scholar]
  3. Brozy J. 2009 Development of Multiplex Serology for HSV-1, HSV-2, EBV and HCMV Using Recombinant Proteins Biosciences Heidelberg: Ruprecht-Karls-Universität Heidelberg;
    [Google Scholar]
  4. Castaño-Vinyals G., Aragonés N., Pérez-Gómez B., Martín V., Llorca J., Moreno V., Altzibar J.M., Ardanaz E., de Sanjosé S., other authors. 2015 [View Article] Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. Gac Sanit
    [Google Scholar]
  5. Cimino P.J. Jr, Bahler D.W., Duncavage E.J. 2013; Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia T-cells. Exp Mol Pathol 94:40–44 [View Article][PubMed]
    [Google Scholar]
  6. Cocco P., Satta G., Dubois S., Pili C., Pilleri M., Zucca M., ’t Mannetje A.M., Becker N., Benavente Y., other authors. 2013; Lymphoma risk and occupational exposure to pesticides: results of the Epilymph study. Occup Environ Med 70:91–98 [View Article][PubMed]
    [Google Scholar]
  7. Comar M., Cuneo A., Maestri I., Melloni E., Pozzato G., Soffritti O., Secchiero P., Zauli G. 2012; Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease. J Clin Virol 55:367–369 [View Article][PubMed]
    [Google Scholar]
  8. Dearden C. 2008; Disease-specific complications of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2008:450–456 [View Article][PubMed]
    [Google Scholar]
  9. Hamblin A.D., Hamblin T.J. 2008; The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull 87:49–62 [View Article][PubMed]
    [Google Scholar]
  10. Haugg A.M., Speel E.-J.M., Pantulu N.D., Pallasch C., Kurz A.K., Kvasnicka H.M., Cathomas G., Wendtner C.-M., zur Hausen A. 2011; Fluorescence in situ hybridization confirms the presence of Merkel cell polyomavirus in chronic lymphocytic leukemia cells. Blood 117:5776–5777 [View Article][PubMed]
    [Google Scholar]
  11. Howard R.A., Dores G.M., Curtis R.E., Anderson W.F., Travis L.B. 2006; Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 15:1545–1549 [View Article][PubMed]
    [Google Scholar]
  12. International Cancer Genome Consortium, Hudson T.J., Anderson W., Artez A., Barker A.D., Bell C., Bernabé R.R., Bhan M.K., Calvo F., other authors. 2010; International network of cancer genome projects. Nature 464:993–998 [View Article][PubMed]
    [Google Scholar]
  13. Imajoh M., Hashida Y., Taniguchi A., Kamioka M., Daibata M. 2012; Novel human polyomaviruses, Merkel cell polyomavirus and human polyomavirus 9, in Japanese chronic lymphocytic leukemia cases. J Hematol Oncol 5:25 [View Article][PubMed]
    [Google Scholar]
  14. Kaae J., Hansen A.V., Biggar R.J., Boyd H.A., Moore P.S., Wohlfahrt J., Melbye M. 2010; Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 102:793–801 [View Article][PubMed]
    [Google Scholar]
  15. Kazem S., van der Meijden E., Feltkamp M.C.W. 2013; The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. APMIS 121:770–782 [View Article][PubMed]
    [Google Scholar]
  16. Kjaerheim K., Røe O.D., Waterboer T., Sehr P., Rizk R., Dai H.Y., Sandeck H., Larsson E., Andersen A., other authors. 2007; Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 120:2459–2465 [View Article][PubMed]
    [Google Scholar]
  17. Koljonen V., Kukko H., Pukkala E., Sankila R., Böhling T., Tukiainen E., Sihto H., Joensuu H. 2009; Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 101:1444–1447 [View Article][PubMed]
    [Google Scholar]
  18. Montserrat E., Moreno C. 2008; Chronic lymphocytic leukaemia: a short overview. Ann Oncol 19:(Suppl 7)vii320–vii325 [View Article][PubMed]
    [Google Scholar]
  19. Nataša Č., Andrija B., Vesna M.-Č., Gradimir J. 2001; Prognostic significance of serum immunoglobulins in B-chronic lymphocytic leukemia. Arch Oncol 9:79–82
    [Google Scholar]
  20. Nicol J.T.J., Touzé A., Robinot R., Arnold F., Mazzoni E., Tognon M., Coursaget P. 2012; Seroprevalence and cross-reactivity of human polyomavirus 9. Emerg Infect Dis 18:1329–1332 [View Article][PubMed]
    [Google Scholar]
  21. Pantulu N.D., Pallasch C.P., Kurz A.K., Kassem A., Frenzel L., Sodenkamp S., Kvasnicka H.M., Wendtner C.M., Zur Hausen A. 2010; Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 116:5280–5284 [View Article][PubMed]
    [Google Scholar]
  22. Paulson K.G., Carter J.J., Johnson L.G., Cahill K.W., Iyer J.G., Schrama D., Becker J.C., Madeleine M.M., Nghiem P., Galloway D.A. 2010; Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res 70:8388–8397 [View Article][PubMed]
    [Google Scholar]
  23. Puente X.S., Pinyol M., Quesada V., Conde L., Ordóñez G.R., Villamor N., Escaramis G., Jares P., Beà S., other authors. 2011; Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101–105 [View Article][PubMed]
    [Google Scholar]
  24. Robles C., Poloczek A., Casabonne D., Gonzalez-Barca E., Bosch R., Benavente Y., Viscidi R.P., de Sanjosé S. 2012; Antibody response to Merkel cell polyomavirus associated with incident lymphoma in the Epilymph case-control study in Spain. Cancer Epidemiol Biomarkers Prev 21:1592–1598 [View Article][PubMed]
    [Google Scholar]
  25. Sant M., Allemani C., Tereanu C., De Angelis R., Capocaccia R., Visser O., Marcos-Gragera R., Maynadié M., Simonetti A., other authors. 2010; Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734 [View Article][PubMed]
    [Google Scholar]
  26. Shuda M., Arora R., Kwun H.J., Feng H., Sarid R., Fernández-Figueras M.-T., Tolstov Y., Gjoerup O., Mansukhani M.M., other authors. 2009; Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125:1243–1249 [View Article][PubMed]
    [Google Scholar]
  27. Slager S.L., Benavente Y., Blair A., Vermeulen R., Cerhan J.R., Costantini A.S., Monnereau A., Nieters A., Clavel J., other authors. 2014; Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014:41–51 [View Article][PubMed]
    [Google Scholar]
  28. Tadmor T., Aviv A., Polliack A. 2011; Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 22:250–256 [View Article][PubMed]
    [Google Scholar]
  29. Teman C.J., Tripp S.R., Perkins S.L., Duncavage E.J. 2011; Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Res 35:689–692 [View Article][PubMed]
    [Google Scholar]
  30. Teras L.R., Rollison D.E., Pawlita M., Michel A., Blase J.L., Willhauck-Fleckenstein M., Gapstur S.M. 2015; Prediagnostic circulating polyomavirus antibody levels and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 24:477–480[PubMed] [CrossRef]
    [Google Scholar]
  31. Toracchio S., Kozinetz C.A., Killen D.E., Sheehan A.M., Banez E.I., Ittmann M.M., Sroller V., Butel J.S. 2009; Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol 46:154–160 [View Article][PubMed]
    [Google Scholar]
  32. Tsiodras S., Samonis G., Keating M.J., Kontoyiannis D.P. 2000; Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc 75:1039–1054 [View Article][PubMed]
    [Google Scholar]
  33. Vanura K., Rieder F., Kastner M.-T., Biebl J., Sandhofer M., Le T., Strassl R., Puchhammer-Stöckl E., Perkmann T., other authors. 2013; Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia. PLoS One 8:e78925 [View Article][PubMed]
    [Google Scholar]
  34. Waterboer T., Sehr P., Michael K.M., Franceschi S., Nieland J.D., Joos T.O., Templin M.F., Pawlita M. 2005; Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51:1845–1853 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000167
Loading
/content/journal/jgv/10.1099/vir.0.000167
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error